{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-007878","form_type":"8-K","ticker":"BCRX","cik":"0000882796","company_name":"BIOCRYST PHARMACEUTICALS INC","filed_at":"2025-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.458825+00:00","generated_at":"2026-05-16T13:36:20.681898+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"BioCryst board chair Nancy Hutson to retire; Vincent Milano named successor","bullets":["Nancy J. Hutson notified retirement from BioCryst board, effective earlier of Astria acquisition close or 2026 annual meeting.","Hutson to continue as Chair and committee member until Retirement Date; cited no disagreement with board or management.","Vincent J. Milano elected as next Board Chair, effective on Hutson's Retirement Date.","Hutson served 14 years on the BioCryst board."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-007878","json":"https://secwatch.observer/filing/0001171843-25-007878.json","markdown":"https://secwatch.observer/filing/0001171843-25-007878.md","text":"https://secwatch.observer/filing/0001171843-25-007878.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882796/000117184325007878/0001171843-25-007878-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882796/000117184325007878/f8k_121125.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:36:20.681898+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}